Paxlovid causes rebound COVID 25% of the time

January 7, 2024- by Steven E. Greer, MD

Researchers led by UCSF studied in a cohort the effects of Pfizer’s Paxlovid on COVID patients outside of the hospital.

“Individuals treated with Paxlovid, (21%) reported rebound symptoms. Among those who repeated antigen testing after testing negative and completing treatment, (25.7%) reported rebound test positivity.”

Click here for the full paper

This entry was posted in - Pharma, CDC, Emergency medicine, Infectious disease. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *